Loading...
Market
Will OncoGAN be integrated into a commercial genomic platform by October 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Press releases or announcements from commercial genomic data analysis companies
Story
New AI Pipeline OncoGAN Generates Synthetic Cancer Genomes, Addressing Privacy Concerns
Oct 21, 2024, 05:57 AM
A novel AI-based pipeline called OncoGAN has been introduced to generate realistic synthetic cancer genomes using generative adversarial networks (GANs) and tabular variational autoencoders (VAEs). This approach addresses the limitations of real patient genomic data due to privacy concerns. The development of OncoGAN aims to facilitate research in precision oncology by providing high-quality synthetic genomic data for algorithm development and benchmarking.
View original story
Similar markets
Yes • 50%
No • 50%
Illumina • 25%
Thermo Fisher Scientific • 25%
Pacific Biosciences • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
